https://www.taxtmi.com/caselaws?id=286766 Imported anti-tubercular medicine containing Rifampicin with other active ingredients was treated as classifiable under tariff heading 3004 90 52 for Rifampicin rather than under the residual heading for other anti-tubercular drugs. The Tribunal accepted the view that the product's composition, read with the tariff entry and the rule on mixtures and combinations, supported classification by reference to Rifampicin. It also upheld the availability of exemption from additional customs duty under the relevant customs notification, as the notification was applied to the import on the facts recorded. en-us Thu, 11 Apr 2019 00:00:00 +0530 Sat, 14 Mar 2020 11:12:42 +0530 TaxTMI RSS Generator https://www.taxtmi.com/caselaws?id=286766 Imported anti-tubercular medicine containing Rifampicin with other active ingredients was treated as classifiable under tariff heading 3004 90 52 for Rifampicin rather than under the residual heading for other anti-tubercular drugs. The Tribunal accepted the view that the product's composition, read with the tariff entry and the rule on mixtures and combinations, supported classification by reference to Rifampicin. It also upheld the availability of exemption from additional customs duty under the relevant customs notification, as the notification was applied to the import on the facts recorded. Case-Laws Customs Thu, 11 Apr 2019 00:00:00 +0530 https://www.taxtmi.com/caselaws?id=286766